Report predicts growth for European molecular imaging markets

01/9/2013 | DOTMed.com

European molecular imaging markets reached $276 million in 2011 and could produce revenues of $388 million in 2018, according to a report from Frost & Sullivan. The report predicts that Italy, Scandinavia and the Benelux region (Belgium, the Netherlands and Luxembourg) will show the earliest growth, followed by France and Spain. Growth will be driven by the increasing adoption of molecular imaging in neurology and the development of advanced modalities such as PET/MR, the report said.

View Full Article in:

DOTMed.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL